Closing the Serological Gap in the Diagnostic Testing for COVID-19: The Value of Anti-SARS-CoV-2 IgA Antibodies
Detection Principle
ImmunoAssay-Antibody
Target
ELISA: IgA, IgG (S1); CLIA: IgM, IgG (S+N)
Testing Method Category
Testing Method
Kits (CLIA and ELISA)
Testing Method - Additional Info
chemiluminescent assay (YHLO Biotech Co Ltd ,Shenzhen, China) and ELISA (Euroimmun Medizinische Labordiagnostika AG Luebeck, Germany)
Reported Performance
Remark: The inclusion of SARS?CoV?2 IgA antibodies may increase the diagnostic sensitivity of the serological tests for COVID?19
Sample Size
30 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements